Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dyne Therapeutics, Inc. | 1,549,288 | reported | 06 May 2026 | tx 94+9,808,428−28,755,185 |
| Epizyme, Inc. | 149,459 | reported | 22 Sept 2014 | tx 46+450,406−608,000 |
| Disc Medicine, Inc. | 17,245 | reported | 04 Oct 2021 | tx 1+17,245 |
| Replimune Group, Inc. | 16,500 | reported | 01 Apr 2022 | tx 81+5,629,886−4,849,340 |
| Generation Bio Co. | 0 | reported | 09 Feb 2026 | tx 59+10,241,232−16,601,717.69 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | SALE | Dyne Therapeutics, Inc. | 3,136 | 18.00 USD | 10b5-1 |
| 04 May 2026 | SALE | Dyne Therapeutics, Inc. | 6,241 | 18.00 USD | 10b5-1 |
| 04 May 2026 | SALE | Dyne Therapeutics, Inc. | 61 | 18.00 USD | 10b5-1 |
| 04 May 2026 | SALE | Dyne Therapeutics, Inc. | 2,466 | 18.00 USD | 10b5-1 |
| 05 May 2026 | SALE | Dyne Therapeutics, Inc. | 3,056 | 18.03 USD | 10b5-1 |
| 05 May 2026 | SALE | Dyne Therapeutics, Inc. | 6,081 | 18.03 USD | 10b5-1 |
| 05 May 2026 | SALE | Dyne Therapeutics, Inc. | 60 | 18.03 USD | 10b5-1 |
| 05 May 2026 | SALE | Dyne Therapeutics, Inc. | 2,403 | 18.03 USD | 10b5-1 |
| 06 May 2026 | SALE | Dyne Therapeutics, Inc. | 21,926 | 18.18 USD | 10b5-1 |
| 06 May 2026 | SALE | Dyne Therapeutics, Inc. | 43,621 | 18.18 USD | 10b5-1 |
| 06 May 2026 | SALE | Dyne Therapeutics, Inc. | 428 | 18.18 USD | 10b5-1 |
| 06 May 2026 | SALE | Dyne Therapeutics, Inc. | 17,244 | 18.18 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 59,870 | 18.38 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 119,115 | 18.38 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 1,170 | 18.38 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 47,082 | 18.38 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 26 | 19.00 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 52 | 19.00 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 1 | 19.00 USD | 10b5-1anomaly |
| 28 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 21 | 19.00 USD | 10b5-1 |
| 23 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 19,261 | 19.19 USD | 10b5-1 |
| 23 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 38,322 | 19.19 USD | 10b5-1 |
| 23 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 377 | 19.19 USD | 10b5-1 |
| 23 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 15,148 | 19.19 USD | 10b5-1 |
| 24 Apr 2026 | SALE | Dyne Therapeutics, Inc. | 36,345 | 18.48 USD | 10b5-1 |
1 purchase reported after at least 12 months of silence — most recent on 12 Dec 2022.